{
  "experiment_info": {
    "experiment_id": "PROT_AD_001",
    "experiment_name": "Alzheimer's Disease Proteomics Study",
    "experiment_date": "2024-10-15",
    "experimenter": "Dr. Jane Smith",
    "lab": "Neuroscience Proteomics Core",
    "description": "Label-free quantification of protein expression in Alzheimer's disease brain tissue vs age-matched controls"
  },
  
  "organism": {
    "species": "Homo sapiens",
    "common_name": "Human",
    "tissue_type": "Brain - frontal cortex",
    "disease_state": ["Control", "Alzheimer's Disease"]
  },
  
  "experimental_design": {
    "design_type": "case-control",
    "number_of_groups": 2,
    "replicates_per_group": 3,
    "total_samples": 6
  },
  
  "mass_spectrometry": {
    "instrument": "Orbitrap Exploris 480",
    "acquisition_mode": "DIA",
    "acquisition_method": "Data-Independent Acquisition",
    "gradient_length_min": 90,
    "ms1_resolution": 120000,
    "ms2_resolution": 30000,
    "isolation_window_width_da": 8,
    "number_of_windows": 40,
    "cycle_time_sec": 2.5,
    "collision_energy": "Stepped HCD (25%, 27.5%, 30%)",
    "chromatography": "C18 reverse phase",
    "flow_rate_nl_min": 300
  },
  
  "sample_preparation": {
    "lysis_buffer": "8M Urea, 50mM Tris-HCl pH 8.0",
    "protein_extraction": "Standard lysis protocol",
    "reduction": {
      "reagent": "DTT",
      "concentration_mm": 10,
      "temperature_c": 56,
      "time_min": 30
    },
    "alkylation": {
      "reagent": "Iodoacetamide",
      "concentration_mm": 25,
      "temperature_c": 25,
      "time_min": 30,
      "notes": "In dark"
    },
    "digestion": {
      "enzyme": "Trypsin",
      "enzyme_to_protein_ratio": "1:50",
      "time_hours": 16,
      "temperature_c": 37
    },
    "desalting": "C18 Sep-Pak",
    "membrane_enrichment": false
  },
  
  "data_analysis_settings": {
    "software": "DIA-NN",
    "version": "1.8.1",
    "spectral_library": {
      "type": "predicted",
      "source": "In-silico deep learning prediction (DIA-NN built-in)",
      "generation_method": "Library-free mode with in-silico library"
    },
    "reference_database": {
      "name": "UniProt Human Reference Proteome",
      "accession": "UP000005640",
      "date": "2024-09-01",
      "entries": 105628,
      "reviewed_only": false,
      "includes_isoforms": true
    },
    "search_parameters": {
      "enzyme": "Trypsin",
      "missed_cleavages": 2,
      "fixed_modifications": ["Carbamidomethyl (C)"],
      "variable_modifications": ["Oxidation (M)", "Acetyl (Protein N-term)"],
      "precursor_tolerance_ppm": 20,
      "fragment_tolerance_ppm": 20,
      "min_peptides_per_protein": 2,
      "min_unique_peptides": 1
    },
    "quantification_settings": {
      "method": "MaxLFQ",
      "ms1_accuracy_ppm": 10,
      "ms2_accuracy_ppm": 15,
      "scan_window": 10,
      "rt_profiling": true,
      "cross_run_normalization": true
    },
    "fdr_settings": {
      "precursor_fdr": 0.01,
      "protein_fdr": 0.01,
      "library_fdr": 0.01,
      "fdr_method": "Target-decoy competition"
    }
  },
  
  "research_context": {
    "protein_of_interest": {
      "uniprot_id": "P02649",
      "gene_name": "APOE",
      "protein_name": "Apolipoprotein E",
      "biological_context": "Major genetic risk factor for Alzheimer's disease, involved in lipid metabolism and amyloid-beta clearance"
    },
    "research_question": "Is APOE differentially expressed in Alzheimer's disease brain tissue compared to age-matched controls?",
    "hypothesis": "APOE protein levels are upregulated in Alzheimer's disease samples",
    "rationale": "APOE is a well-established AD risk factor. Literature suggests altered APOE expression in AD pathology."
  },
  
  "file_locations": {
    "raw_data_files": "DIA_raw_files/*.raw",
    "sample_data": "scenario_2_sample_data.csv",
    "assay_data": "scenario_2_assay_data.csv",
    "output_directory": "analysis_output/"
  }
}
